Healthy Extracts Inc Stock Price, News & Analysis

Healthy Extracts Inc. (OTCQB: HYEX) reported strong fourth quarter and full year results for 2021, showcasing a net revenue of $672,000 in Q4, up 77% sequentially and 394% year-over-year. The company reversed its previous net loss, achieving a net income of $535,000. Annual revenue increased 15% to a record $1.5 million, with gross profit at $695,000, representing 47.4% of net revenue. Healthy Extracts launched innovative nutraceuticals, including Ultimate Brain Nutrients™, and engaged brand influencer Whitney Johns to boost market presence.

Healthy Extracts Inc. (OTCQB: HYEX) has launched an educational initiative on its YouTube channel to promote its clinically proven plant-based products for heart and brain health. The channel will feature informative content, including interviews with founders and product development teams, as well as influencers like Whitney Johns. The company recently published strong clinical trial results for its product UBN RELIEF, demonstrating significant benefits for migraine sufferers and cognitive function. With 100+ clinical studies backing its formulations, Healthy Extracts aims for over 100% sales growth in 2022.

Healthy Extracts Inc. (OTCQB: HYEX) has announced over 100% sales growth for 2022, driven by its innovative, clinically proven plant-based products targeting brain and heart health. The company's Ultimate Brain Nutrients™ and Citrus Bergamot SuperFruit™ formulations are positioned in rapidly expanding markets, with brain health projected to reach $24.6 billion and heart health $24.8 billion by 2027. Healthy Extracts launched new products and received follow-on orders from distributors, expecting continued growth with revenue estimated at $1.7 million for 2021, marking a 31% increase.

Healthy Extracts Inc. (OTCQB: HYEX) has announced significant results from a prospective, randomized, double-blind, placebo-controlled trial of UBN RELIEF™, a formulation aimed at alleviating migraine symptoms. The 60-day study showed a 53% reduction in migraine incidents, 39% decrease in duration, and 27% less pain severity. Additionally, participants reported a 43% improvement in quality of life and a 55% reduction in time lost due to migraines. No adverse side effects were noted, highlighting its potential as a safe alternative for the millions suffering from migraines.

Healthy Extracts Inc. (HYEX) has extended its exclusive marketing contract for Citrus Bergamot SuperFruit™ with Herbal & Antioxidant Derivatives, S.r.l. until December 31, 2023. This contract gives Healthy Extracts a competitive edge, allowing them to distribute the highest strength Citrus Bergamot with 47% BPF potency, surpassing competitors’ 38% BPF. The company anticipates at least 100% organic revenue growth for 2022, with predicted gross revenues reaching approximately $1.7 million, a 31% increase year-over-year. The heart-health supplement market is projected to grow significantly, reaching $24.8 billion by 2027.

Healthy Extracts (OTCQB: HYEX) reported strong preliminary results for Q4 and full year 2021. Q4 gross revenue is expected to be around $770,000, a 72% sequential increase and over 519% year-over-year. Full year revenue is projected at $1.7 million, up 31%. The company highlights a growing customer base with a lifetime value exceeding $500. Key developments include two new high-potency formulations leveraging Citrus Bergamot SuperFruit™, aiming for 100% organic revenue growth in 2022. Healthy Extracts plans to release full year results by March end.

Healthy Extracts Inc. (OTCQB: HYEX) has appointed J. Scott Landers as executive vice president of sales and marketing. Landers brings over 20 years of experience from notable companies like KPMG and IBM, focusing on product launches and revenue growth. He expressed enthusiasm about joining the company during a pivotal growth stage and aims to expand distribution channels and product offerings. President Duke Pitts anticipates Landers’ expertise will drive sales growth and enhance market reach, particularly in B2B distribution and subscription-based offerings.

Healthy Extracts Inc. (OTCQB: HYEX) has secured follow-on purchase orders for its Citrus Bergamot SuperFruit™ from XYMOGEN and other distributors. This marks a return to growth in B2B distribution after pandemic-related challenges. The President of Healthy Extracts indicates potential for further product introductions through XYMOGEN’s WholeScripts platform. The exclusive order is part of a performance-based engagement, emphasizing the health benefits of the SuperFruit for cardiovascular health. XYMOGEN distributes to over 20,000 medical professionals, highlighting strong market potential.